REG - hVIVO plc - Award of Share Options <Origin Href="QuoteRef">HVO.L</Origin>

hVIVOAnnouncement

15/07/2015 14:00

RNS Number : 8997K
hVIVO plc
21 April 2015
For immediate release: 21 April 2015
HVIVO PLC
("hVIVO" or the "Company")
Award of Share Options
hVIVO plc (AIM: HVO), the pioneer of human challenge models of disease, announces that on 21 April 2015 it awarded the following options over ordinary shares of 5.0p each in the Company to certain Directors:
Name
Position
Number of Share Options Awarded
Exercise price per Share
Date of Vesting
Percentage of issued ordinary share capital
Kym Denny
Chief Executive Officer
111,193
337.25p
21 April 2018
0.16%
Graham Yeatman
Chief Financial & Business Officer
88,955
337.25p
21 April 2018
0.13%
For further information please contact:
hVIVO plc +44 207 756 1300
Kym Denny (CEO)
Graham Yeatman (FD) 
Media Enquiries+44 203 021 3933 / +44 7854 979 420
Colin Paterson (Director of Marketing, Communication and Public Relations)
 
Numis Securities Limited  +44 207 260 1000 
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases. Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSUASSRVAASUAR